These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular aspects of vasopressin receptor function. Schöneberg T; Kostenis E; Liu J; Gudermann T; Wess J Adv Exp Med Biol; 1998; 449():347-58. PubMed ID: 10026824 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones. Cheong HI; Cho HY; Park HW; Ha IS; Choi Y Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330 [TBL] [Abstract][Full Text] [Related]
5. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function. Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826 [TBL] [Abstract][Full Text] [Related]
6. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model. Robben JH; Knoers NV; Deen PM Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591 [TBL] [Abstract][Full Text] [Related]
7. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. Tsukaguchi H; Matsubara H; Taketani S; Mori Y; Seido T; Inada M J Clin Invest; 1995 Oct; 96(4):2043-50. PubMed ID: 7560098 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant. Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187 [TBL] [Abstract][Full Text] [Related]
9. Polarized expression of the vasopressin V2 receptor in Madin-Darby canine kidney cells. Andersen-Beckh B; Dehe M; Schülein R; Wiesner B; Rutz C; Liebenhoff U; Rosenthal W; Oksche A Kidney Int; 1999 Aug; 56(2):517-27. PubMed ID: 10432391 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells. Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A Br J Pharmacol; 1998 Dec; 125(7):1463-70. PubMed ID: 9884074 [TBL] [Abstract][Full Text] [Related]
11. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus. Robben JH; Sze M; Knoers NV; Deen PM Am J Physiol Renal Physiol; 2007 Jan; 292(1):F253-60. PubMed ID: 16926443 [TBL] [Abstract][Full Text] [Related]
14. [Molecular biological studies on patients with nephrogenic diabetes insipidus]. Szalai C; Molnár E; Sallay P; Czinner A Orv Hetil; 1998 Apr; 139(15):883-7. PubMed ID: 9579101 [TBL] [Abstract][Full Text] [Related]
15. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors. Schwieger I; Lautz K; Krause E; Rosenthal W; Wiesner B; Hermosilla R Mol Pharmacol; 2008 Mar; 73(3):697-708. PubMed ID: 18048502 [TBL] [Abstract][Full Text] [Related]
16. C112R, W323S, N317K mutations in the vasopressin V2 receptor gene in patients with nephrogenic diabetes insipidus. Mutations in brief no. 165. Online. Szalai C; Triga D; Czinner A Hum Mutat; 1998; 12(2):137-8. PubMed ID: 10694923 [TBL] [Abstract][Full Text] [Related]
17. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Li D; Duan L; Freimuth P; O'Malley BW Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357 [TBL] [Abstract][Full Text] [Related]